Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists-Reference-Cited by-同舟云学术

Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists

Published:2017-09-25 Issue:11 Volume:15 Page:2165-2175
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Nagler M.¹²^ORCID,Angelillo-Scherrer A.¹²,Méan M.³⁴,Limacher A.⁵,Abbal C.⁶,Righini M.⁷,Beer J. H.⁸,Osterwalder J.⁹,Frauchiger B.¹⁰,Aschwanden M.¹¹,Matter C. M.¹²,Kucher N.¹³,Cornuz J.¹⁴,Banyai M.¹⁵,Husmann M.¹⁶,Staub D.¹¹,Mazzolai L.¹⁷,Hugli O.¹⁸,Rodondi N.³¹⁹,Aujesky D.⁴

Affiliation:

1. Department of Haematology and Central Haematology Laboratory, Inselspital; Bern University Hospital; University of Bern; Bern Switzerland

2. Department of Clinical Research; University of Bern; Bern Switzerland

3. Department of General Internal Medicine; Bern University Hospital; University of Bern; Bern Switzerland

4. Division of General Internal Medicine; Lausanne University Hospital; Lausanne Switzerland

5. CTU Bern, and Institute of Social and Preventive Medicine (ISPM); University of Bern; Bern Switzerland

6. Division of Hematology; Lausanne University Hospital; Lausanne Switzerland

7. Division of Angiology and Hemostasis; Geneva University Hospital; Geneva Switzerland

8. Cantonal Hospital of Baden; Baden Switzerland

9. Emergency Department; Cantonal Hospital of St Gallen; St Gallen Switzerland

10. Department of Internal Medicine; Cantonal Hospital of Frauenfeld; Frauenfeld Switzerland

11. Division of Angiology; Basel University Hospital; Basel Switzerland

12. Center for Molecular Cardiology; University of Zurich and University Heart Center; University Hospital Zurich; Zurich Switzerland

13. Division of Angiology; Bern University Hospital; University of Bern; Bern Switzerland

14. Department of Ambulatory Care and Community Medicine; University of Lausanne; Lausanne Switzerland

15. Division of Angiology; Cantonal Hospital of Lucerne; Lucerne Switzerland

16. Division of Angiology; Zurich University Hospital and University of Zurich; Zurich Switzerland

17. Service of Angiology; Lausanne University Hospital; Lausanne Switzerland

18. Emergency Department; Lausanne University Hospital; Lausanne Switzerland

19. Institute of Primary Health Care; University of Bern; Bern Switzerland

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13810/fullpdf

Reference70 articles.

1. Pharmacogenomics: historical perspective and current status;Charlab;Methods Mol Biol,2013

2. Is individualized medicine more cost-effective? A systematic review;Hatz;Pharmacoeconomics,2014

3. Next-generation medicines: past regulatory experience and considerations for the future;Pacanowski;Clin Pharmacol Ther,2014

4. Pharmacogenetics and coumarin dosing-recalibrating expectations;Zineh;N Engl J Med,2013

5. Pharmacoeconomics in the era of individualized medicine;Waldman;Clin Pharmacol Ther,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary prevention of venous thromboembolism: Predictors and outcomes of guideline adherence in a long-term prospective cohort study;Frontiers in Cardiovascular Medicine;2022-08-03

2. Long-Term Survival After Venous Thromboembolism: A Prospective Cohort Study;Frontiers in Cardiovascular Medicine;2021-10-01

3. Rivaroxaban in patients with mechanical heart valves: A pilot study;Thrombosis Research;2020-02

4. Phenprocoumon Dose Requirements, Dose Stability and Time in Therapeutic Range in Elderly Patients With CYP2C9 and VKORC1 Polymorphisms;Frontiers in Pharmacology;2020-01-28

5. Genetic and Molecular Testing in Thrombosis and Hemostasis: Informing Surveillance, Treatment, and Prognosis;Seminars in Thrombosis and Hemostasis;2019-04-30